Fenofibrate use associated with higher overall death rates, increased rates of death from heart disease and increased rates of pancreatitis & pulmonary embolism

Published in the Lancet 2005, vol. 366, no9500, pp. 1829-1831, pp. 1849-1861

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study) : randomised controlled trial. Commentary

Helen Colhoun Conway Institute, University Collège Dublin, Dublin, IRLANDE

This study can be accessed at: http://cat.inist.fr/?aModele=afficheN&cpsidt=17303544
 
The author found that Fenofibrate use was associated with higher overall death rates, increased rates of death from heart disease and increased rates of pancreatitis & pulmonary embolism.

AMAZON UK Malignant Medical Myths: Why Medical Treatment Causes 200,000 Deaths in the USA Each Year.
AMAZON USA Malignant Medical Myths: Why MEdical Treatment Causes 200,000 Deaths in the USA each Year, and How to Protect Yourself

ADVERT: Click here for Dr. Mercola's Total Health Breakthrough. Dr. Joseph Mercola's complete guide to weight loss, preventing disease and premature aging, and living healthy and longer.

Click here to find out how to get the FREE shopping APP that finds you the cheapest prices for all your shopping